Toward the same direction, another study has evaluated the prognostic significance of promoter methylation of seven genes (APC, BRCA1, CCND2, FOXA1, PSAT1, RASSF1A, and SCGB3A1) in primary tissues and cfDNA of breast cancer patients [31]. This evidence concerns the gene CCND2 and breast carcinoma.